0001641172-25-000770.txt : 20250326 0001641172-25-000770.hdr.sgml : 20250326 20250326170012 ACCESSION NUMBER: 0001641172-25-000770 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250326 DATE AS OF CHANGE: 20250326 EFFECTIVENESS DATE: 20250326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioSig Technologies, Inc. CENTRAL INDEX KEY: 0001530766 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 264333375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-542237 FILM NUMBER: 25774106 BUSINESS ADDRESS: STREET 1: 55 GREENS FARMS ROAD CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: (203) 409-5444 MAIL ADDRESS: STREET 1: 55 GREENS FARMS ROAD CITY: WESTPORT STATE: CT ZIP: 06880 D 1 primary_doc.xml X0708 D LIVE 0001530766 BioSig Technologies, Inc. 12424 WILSHIRE BLVD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 (203) 409-5444 DELAWARE None None Corporation true Anthony Amato 12424 WILSHIRE BLVD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Executive Officer Director Chief Executive Officer Ferdinand Groenewald 12424 WILSHIRE BLVD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Executive Officer Chief Financial Officer Steven E. Abelman 12424 WILSHIRE BLVD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Donald F. Browne 12424 WILSHIRE BLVD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Chris Baer 12424 WILSHIRE BLVD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Frederick D. Hrkac 12424 WILSHIRE BLVD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Other Health Care Decline to Disclose 06b false 2025-03-05 false true true false 0 None None None None None None None XX Unknown None CA CALIFORNIA CT CONNECTICUT FL FLORIDA MI MICHIGAN NJ NEW JERSEY NC NORTH CAROLINA false 818998 818998 0 The Issuer sold an aggregate of 758,514 shares of the Company's common stock at a purchase price of $1.07974 per share and warrants to purchase up to 758,514 shares of common stock at an exercise price of $0.95474 per share. false 11 0 0 0 false BioSig Technologies, Inc. /s/ Anthony Amato Anthony Amato Chief Executive Officer 2025-03-26